MOC-etomidate is an etomidate analogue that retains etomidate's important favorable pharmacological properties. However, it is rapidly metabolized, ultra-short-acting, and does not produce prolonged adrenocortical suppression after bolus administration.
No takes yet. Share an insight, caveat, or question.
Cotten et al. (2009) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: